General Application

We engineer stem cell transplants that shield healthy cells from targeted therapies Targeted therapies work by attacking cells that express particular proteins on their surface.

Unfortunately, both diseased and healthy cells often express the same proteins, resulting in collateral damage to healthy cells.

At Vor Bio, we engineer hematopoietic stem cells (HSCs) to lack a biologically redundant target protein, then transplant these cells into the patient.

These eHSCs give rise to generations of n…